title: Fibroblast apoptosis and caspase-8 activation in aseptic loosening.
abstract: The presence of apoptosis has been investigated in the interface membranes collected during revision surgery of loosened total hip joint arthroplasty (THAs). Terminal deoxyrobonucleotidyl transferase (TdT) assay for apoptotic DNA fragmentation quantification revealed a statistically significant presence of apoptosis in aseptic samples, obtained from both cementless (2.37+/-0.6%) and cemented (12.01+/-1%) prosthesis compared to septic samples where apoptosis was almost absent. Activated caspase-8 immunostaining was almost undetectable in septic samples, while in the aseptic samples active caspase-8 was present weakly in the cementless samples (1.35+/-0.22%) and strongly in the cemented ones (9.0+/-0.40%). The caspase-8 cytoplasmatic staining allowed the morphological recognition of positive cells both as fibroblast-like and immunocompetent cells. In aseptic cemented samples fibroblast-like cells were the most represented subpopulation in the caspase-8 positive population scored (76.6%) compared to the immunocompetent cells (23.4%). Caspase-8 activation is an upstream event in the apoptotic pathway triggered by the activation of cytokines receptors such as TNF-alpha receptor 1 (TNFR-1), and the presence of caspase-8 activation in fibroblast-like cells in the aseptic interface membranes of THAs suggests a possible TNF-alpha dependent apoptosis.
authors.affiliation: Human Anatomy Laboratory, Research Center for Biocompatibility, Medical Sciences Department, University of Eastern Piedmont "A. Avogadro", Via Solaroli 17, 28100 Novara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Renò
authors.forename: M
authors.initials: M
authors.lastname: Sabbatini
authors.forename: A
authors.initials: A
authors.lastname: Massè
authors.forename: M
authors.initials: M
authors.lastname: Bosetti
authors.forename: M
authors.initials: M
authors.lastname: Cannas
mesh_terms: D017209:Apoptosis; D019644:Arthroplasty, Replacement, Hip; D001672:Biocompatible Materials; D053181:Caspase 8; D020169:Caspases / Q000378:metabolism*; D053938:DNA Fragmentation; D004789:Enzyme Activation; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D011475:Prosthesis Failure; D013997:Time Factors
chemical_list: D001672:Biocompatible Materials; C505530:CASP8 protein, human; D053181:Caspase 8; D020169:Caspases